WNK2 and cardiac hypertrophy: Pivotal signaling pathways that functioned in the pathogenesis of cardiac hypertrophy, including the mitogen-activated protein kinases (MAPKs) and AKT pathways, were assessed [10], [27], [29], [30], [31].